1. Home
  2. CNDT vs VALN Comparison

CNDT vs VALN Comparison

Compare CNDT & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNDT
  • VALN
  • Stock Information
  • Founded
  • CNDT 2016
  • VALN 2012
  • Country
  • CNDT United States
  • VALN France
  • Employees
  • CNDT N/A
  • VALN N/A
  • Industry
  • CNDT Business Services
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CNDT Consumer Discretionary
  • VALN Health Care
  • Exchange
  • CNDT Nasdaq
  • VALN Nasdaq
  • Market Cap
  • CNDT 497.6M
  • VALN 510.7M
  • IPO Year
  • CNDT N/A
  • VALN 2021
  • Fundamental
  • Price
  • CNDT $2.16
  • VALN $6.18
  • Analyst Decision
  • CNDT
  • VALN Strong Buy
  • Analyst Count
  • CNDT 0
  • VALN 3
  • Target Price
  • CNDT N/A
  • VALN $15.33
  • AVG Volume (30 Days)
  • CNDT 1.3M
  • VALN 86.0K
  • Earning Date
  • CNDT 05-07-2025
  • VALN 05-07-2025
  • Dividend Yield
  • CNDT N/A
  • VALN N/A
  • EPS Growth
  • CNDT N/A
  • VALN N/A
  • EPS
  • CNDT 1.54
  • VALN N/A
  • Revenue
  • CNDT $3,186,000,000.00
  • VALN $201,099,222.00
  • Revenue This Year
  • CNDT N/A
  • VALN $18.74
  • Revenue Next Year
  • CNDT $2.53
  • VALN $29.26
  • P/E Ratio
  • CNDT $1.40
  • VALN N/A
  • Revenue Growth
  • CNDT N/A
  • VALN 21.64
  • 52 Week Low
  • CNDT $1.90
  • VALN $3.62
  • 52 Week High
  • CNDT $4.90
  • VALN $9.50
  • Technical
  • Relative Strength Index (RSI)
  • CNDT 44.64
  • VALN 42.14
  • Support Level
  • CNDT $2.18
  • VALN $6.15
  • Resistance Level
  • CNDT $2.42
  • VALN $6.55
  • Average True Range (ATR)
  • CNDT 0.13
  • VALN 0.23
  • MACD
  • CNDT 0.03
  • VALN -0.01
  • Stochastic Oscillator
  • CNDT 50.00
  • VALN 6.00

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: